Consulting

Addressing the Risks of Nitrosamine Contamination in Pharmaceuticals: 2023 RAPS Article of The Year

Meet Our Speakers:

Dr. Olu Aloba
Vice President, CMC Services

Dr. Marianthi Karakatsani
Director, CMC Development Strategy

Medical and Regulatory Affairs

FDA’s Final Rule on LDTs and Its Impact on Clinical and Regulatory Professionals

By Charles Chrisawn

April 30, 2024

Consulting

3 Characteristics of a Successful Cell and Gene Therapy Nonclinical Program

By Madelyn Huang

April 24, 2024

Enhancing Clinical Trial Accessibility – Bringing Oncology Trials to Patients

Listen Now